Analyst Ratings Network logo

NASDAQ:EAR - Eargo Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $48.00
  • Forecasted Upside: -12.58 %
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
$54.91 As of 01/19/2021 01:00 AM ET
▲ +0.13 (0.24%)
1 month | 3 months | 12 months
Get New Eargo Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for EAR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for EAR

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$48.00
▼ -12.58% Downside Potential
This price target is based on 4 analysts offering 12 month price targets for Eargo in the last 3 months. The average price target is $48.00, with a high forecast of $60.00 and a low forecast of $41.00. The average price target represents a -12.58% upside from the last price of $54.91.
Buy
The current consensus among 4 investment analysts is to buy stock in Eargo.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/30/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/28/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/26/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/25/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/24/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/22/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/21/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/20/2021

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/13/2021Wells Fargo & CompanyBoost Price Target$53.00 ➝ $60.00High
i
11/11/2020Bank of AmericaInitiated CoverageBuy$43.00Low
i
11/10/2020JPMorgan Chase & Co.Initiated CoverageOverweight$41.00Medium
i
11/10/2020Wells Fargo & CompanyInitiated CoverageOverweight$45.00Medium
i
11/10/2020William BlairInitiated CoverageOutperformMedium
i
Rating by M. Kaczor at William Blair
(Data available from 1/20/2016 forward)
Eargo logo
Eargo, Inc., a consumer-focused medical device company, develops and sells hearing aids to assist people with hearing loss in the United States. It sells its products through online stores. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2014. Eargo, Inc. was founded in 2010 and is headquartered in San Jose, California.
Read More

Today's Range

Now: $54.91
$50.80
$57.56

50 Day Range

MA: $50.48
$42.50
$59.78

52 Week Range

Now: $54.91
$32.58
$62.99

Volume

475,580 shs

Average Volume

350,031 shs

Market Capitalization

$2.10 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Eargo?

The following equities research analysts have issued stock ratings on Eargo in the last twelve months: Bank of America Co., JPMorgan Chase & Co., Wells Fargo & Company, William Blair, and Zacks Investment Research.

What is the current price target for Eargo?

3 Wall Street analysts have set twelve-month price targets for Eargo in the last year. Their average twelve-month price target is $48.00, suggesting a possible downside of 12.6%. Wells Fargo & Company has the highest price target set, predicting EAR will reach $60.00 in the next twelve months. JPMorgan Chase & Co. has the lowest price target set, forecasting a price of $41.00 for Eargo in the next year.

What is the current consensus analyst rating for Eargo?

Eargo currently has 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe EAR will outperform the market and that investors should add to their positions of Eargo.

What other companies compete with Eargo?

Other companies that are similar to Eargo include MSA Safety, Avanos Medical, Establishment Labs, Inogen, Invacare, Sanara MedTech, Sientra, Lakeland Industries, Histogenics, United Health Products, Alpha Pro Tech, Surgalign, Milestone Scientific, Conformis and Nutriband.

How do I contact Eargo's investor relations team?

The company's listed phone number is 650-351-7700 and its investor relations email address is ir@eargo.com. The official website for Eargo is eargo.com.